NCT02759354View on ClinicalTrials.gov

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

PHASE3CompletedINTERVENTIONAL
Enrollment

754

Participants

Timeline

Start Date

April 26, 2016

Primary Completion Date

July 29, 2016

Study Completion Date

August 1, 2016

Conditions
Hepatitis BPertussis
Interventions
OTHER

Blood Sample

Blood sample at approx. 4 years of age

Sponsors

Lead Sponsor

MCM Vaccines B.V.
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

MCM Vaccines B.V.

INDUSTRY

NCT02759354 - Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) | Biotech Hunter | Biotech Hunter